Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2005-07-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JCHROMB.2005.05.006PMID 15951253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression

  2004cited by this paper
• The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression.

  2004cited by this paper
• Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines

  2003cited by this paper
• Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats.

  2003cited by this paper
• Effects of the Phytoestrogens Genistein and Daidzein on BRCA2 Tumor Suppressor Gene Expression in Breast Cell Lines

  2003cited by this paper
• BRCA1 gene in breast cancer

  2003cited by this paper
• Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.

  2003cited by this paper
• Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.

  2003cited by this paper
• Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines

  2002cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• Insights into DNA recombination from the structure of a RAD51–BRCA2 complex

  2002cited by this paper
• Chromosome segregation: playing polo in prophase.

  2002cited by this paper
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001cited by this paper
• Determination of BRCA2 oncosuppressor protein expression in human mammary cells by affinity perfusion high-performance chromatography.

  2001cited by this paper
• Ataxia Telangiectasia Mutated (ATM) Kinase and ATM and Rad3 Related Kinase Mediate Phosphorylation of Brca1 at Distinct and Overlapping Sites

  2001cited by this paper
• Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

  2000cited by this paper
• Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.

  2000cited by this paper
• Roles of BRCA1 and its interacting proteins

  2000cited by this paper
• The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase

  2000cited by this paper
• Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage.

  2000cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• Isolation, purification and quantification of BRCA1 protein from tumour cells by affinity perfusion chromatography.

  1999cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

  1998cited by this paper
• Polo-like kinases: a team that plays throughout mitosis.

  1998cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• Polo-like kinases: positive regulators of cell division from start to finish.

  1998cited by this paper
• Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers.

  1997cited by this paper
• Cross‐reaction between antibodies raised against the last 20 C‐terminal amino acids of BRCA 1 (C‐20) and human EGF and EGF‐R in MCF 10a human mammary epithelial cell line

  1997cited by this paper
• Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region

  1997cited by this paper
• BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

  1997cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Comparison of Class II HLA antigen expression in normal and carcinomatous human breast cells.

  1985cited by this paper
• Breast tumor cell lines from pleural effusions.

  1974cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• Special bioactive compounds and functional foods may exhibit neuroprotective effects in patients with dementia (Review)

  2020cites this paper
• Breast Cancer and Lycopene

  2019cites this paper
• Purification of baculovirus vectors using heparin affinity chromatography

  2016cites this paper
• BRCA1 and p53 Tumor Suppressor Molecules in Alzheimer’s Disease

  2015cites this paper
• Perfusive ion-exchange chromatographic materials with high capacity.

  2014cites this paper
• Treatment With Lycopene and Correlation With RT-QPCR , and Cx43 in Breast Tumor Cell Lines After β , RAR α Immunohistochemical Expression of RAR

  2013cites this paper
• The Role of Tomato Lycopene in Cancer Prevention

  2011cites this paper
• Nutrigenomics and antioxidants.

  2008cites this paper
• Immunohistochemical expression of RARalpha, RARbeta, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR.

  2007cites this paper
• Immunohistochemical Expression of RARα, RARβ, and Cx43 in Breast Tumor Cell Lines After Treatment With Lycopene and Correlation With RT-QPCR

  2007cites this paper